Description of Side Effects of Using Antituberculosis Drug in Pulmonary Tuberculosis Patients: Literature Review

Hasna Nisrina; Indah Laily  Hilmi

Authors

Hasna Nisrina Universitas Singaperbangsa Karawang
Indah Laily Hilmi Universitas Singaperbangsa

Abstract

Pulmonary tuberculosis (TB) is a chronic and infectious disease that is still a global concern. The bacterium that causes tuberculosis is the bacterium Mycobacterium tuberculosis. The high incidence of tuberculosis is due to the rapid spread of bacteria caused by the easy transmission of the disease, namely through the droplet nucleus containing Mycobacterium tuberculosis. Tuberculosis morbidity and mortality is a serious problems, especially due to the emergence of side effects of Anti Tuberculosis Drugs (OAT). most sufferers feel unable to tolerate the side effects of OAT experienced during the treatment process. This study aimed to determine the side effects felt by patients with pulmonary tuberculosis who used antituberculosis drugs. The most widely used method is the descriptive method with a cross-sectional approach with different data collection. The results showed that side complaints caused by OAT ranged from mild effects: nausea, abdominal pain, joint pain, tingling, and red urine to severe side effects, namely respiratory syndrome (shortness of breath), itching, and redness of the skin, deafness, jaundice. without other causes, visual disturbances, and vomiting.

References

T. Kristini and R. Hamidah, “Potensi Penularan Tuberculosis Paru pada Anggota Keluarga Penderita,” J. Kesehat. Masy. Indones., vol. 15, no. 1, p. 24, 2020, doi: 10.26714/jkmi.15.1.2020.24-28.

S. Rahmah, H. Ariyani, D. Hartanto, F. Farmasi, and S. Naranjo, “Studi Literatur Analisis Efek Samping Obat pada Pasien Tuberkulosis (Literature Study Analysis of Drug Side Effects on Tuberculosis Patients),” J. Curr. Pharm. Sci., vol. 4, no. 2, pp. 395–405, 2021, [Online]. Available: https://journal.umbjm.ac.id/index.php/jcps/article/view/727%0AEfek samping obat, Obat antituberculosis, Skala Naranjo, Tuberkulosis.

M. Musdalipah; Nurhikmah, Eny; Karmilah, Fakhrurazi, “Efek Samping Obat Anti Tuberkulosis ( Oat ) Dan Penanganannya Pada Pasien Tuberkulosis ( Tb ) Di Puskesmas Perumnas Kota Kendari,” J. Imiah Manuntun, vol. 4, no. 1, pp. 67–73, 2018, [Online]. Available: http://jurnal.akfarsam.ac.id/index.php/jim_akfarsam/article/view/144.

E. P. Pratiwi, E. Rohmawaty, and I. D. Kulsum, “Efek Samping Obat Anti Tuberkulosis Kategori I dan II Pasien Tuberkolosis Paru Dewasa di Rumah Sakit Hasan Sadikin,” Indones. J. Clin. Pharm., vol. 7, no. 4, p. 252, 2018, doi: 10.15416/ijcp.2018.7.4.252.

F. Amining, H. Herawanto, D. S. Syahadat, H. Hasanah, and H. Hasanah, “Pengaruh Peran Pengawas Menelan Obat dan Efek Samping Obat Anti Tuberkulosis Terhadap Angka Kesembuhan (Cure Rate) Pasien Tuberkulosis,” Prev. J. Kesehat. Masy., vol. 12, no. 2, p. 386, 2021, doi: 10.22487/preventif.v12i2.451.

A. Abbas, “Monitoring Efek Samping Obat Anti-Tuberkulosis (OAT) Pada Pengobatan Tahap Intensif Penderita TB Paru Di Kota Makassar,” J. Agromedicine Med. Sci., vol. 3, no. 1, pp. 19–24, 2017.

W. Abdulkadir, N. Djuwarno, N. Rasdianah, and F. Hiola, “Gambaran Efek Samping Obat Antituberkulosis Pada Pasien Tuberkulosis,” J. Syifa Sci. Clin. Res., vol. 4, no. 1, pp. 267–274, 2022, [Online]. Available: http://ejurnal.ung.ac.id/index.php/jsscr,E-DOI:https://doi.org/10.37311/jsscr.v4i1.14220.

P. A. Wiratmo, W. Setyaningsih, and Fitriani, “Riwayat Pengobatan, Efek Samping Obat dan Penyakit Penyerta Pasien Tuberkulosis Paru Terhadap Tingkat Kepatuhan Berobat,” CoMPHI J. Community Med. Public Heal. Indones. J., vol. 2, no. 1, pp. 30–36, 2021, doi: 10.37148/comphijournal.v2i1.46.

A. Asriati, L. O. Alifariki, and A. Kusnan, “Faktor Risiko Efek Samping Obat dan Merasa Sehat Terhadap Ketidakpatuhan Pengobatan Penderita Tuberkulosis Paru,” J. Kesehat. PERINTIS (Perintis’s Heal. Journal), vol. 6, no. 2, pp. 134–139, 2019, doi: 10.33653/jkp.v6i2.344.

A. D. S. S. Fraga, N. Oktavia, and R. A. Mulia, “Evaluasi Penggunaan Obat Anti Tuberkulosis Pasien Baru Tuberkulosis Paru Di Puskesmas Oebobo Kupang,” J. Farmagazine, vol. 8, no. 1, p. 17, 2021, doi: 10.47653/farm.v8i1.530.

B. A. Christy and N. Ressi Susanti, “Hubungan Tingkat Kepatuhan Minum Obat Pasien Tuberkulosis Terhadap Efek Samping Obat Anti Tuberkulosis ( OAT ),” J. Syifa Sci. Clin. Res., vol. 4, pp. 484–493, 2022.